Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × azaspirane × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Neuroendocrine 2 Carcinoma 1 Carcinoid Tumor 1

Interventions

Everolimus 3 Sunitinib 2 Octreotide 2 repotrectinib 1 pralsetinib 1 pasireotide 1 lutetium Lu 177 dotatate 1 epothilone B 1 cixutumumab 1 belinostat 1 azaspirane 1 avelumab 1 Radiotherapy 1 Lutetium-177 1 Etoposide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00388063 2007-12-21

Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

Callisto Pharmaceuticals

Phase 2 Completed

Carcinoid Tumor, Carcinoma, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡